PMV Pharmaceuticals Inc. (PMVP)
1.36
0.01 (0.74%)
At close: Jan 15, 2025, 11:17 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 1.26M | 650.00K | 1.28M | 318.00K | 388.00K | 338.00K |
| Gross Profit | -1.26M | -650.00K | -1.28M | -318.00K | -388.00K | -338.00K |
| Operating Income | -80.13M | -77.04M | -58.29M | -34.94M | -26.64M | -18.89M |
| Interest Income | 11.17M | 3.63M | 449.00K | 651.00K | 1.30M | 1.34M |
| Pretax Income | -68.96M | -73.33M | -57.82M | -34.43M | -25.34M | -17.54M |
| Net Income | -68.96M | -73.32M | -57.85M | -34.44M | -25.35M | -17.54M |
| Selling & General & Admin | 24.25M | 25.05M | 21.80M | 11.01M | 5.88M | 5.04M |
| Research & Development | 54.63M | 51.99M | 36.49M | 23.93M | 20.76M | 13.85M |
| Other Expenses | n/a | 87.00K | 21.00K | -143.00K | -8.00K | 16.00K |
| Operating Expenses | 80.13M | 77.04M | 58.29M | 34.94M | 26.64M | 18.89M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 80.13M | 77.04M | 58.29M | 34.94M | 26.64M | 18.89M |
| Income Tax | 2.00K | -9.00K | 23.00K | 6.00K | 8.00K | 3.00K |
| Shares Outstanding (Basic) | 48.01M | 45.59M | 45.14M | 44.78M | 43.00M | 31.23M |
| Shares Outstanding (Diluted) | 48.01M | 45.59M | 45.14M | 44.78M | 43.00M | 31.23M |
| EPS (Basic) | -1.44 | -1.61 | -1.28 | -0.77 | -0.59 | -0.56 |
| EPS (Diluted) | -1.44 | -1.61 | -1.28 | -0.77 | -0.59 | -0.56 |
| EBITDA | -78.88M | -76.72M | -57.99M | -34.62M | -26.25M | -18.55M |
| Depreciation & Amortization | 1.26M | 650.00K | 1.28M | 318.00K | 388.00K | 338.00K |